血管化:治愈的方法在哪里?
1Department of Geriatrics, Peking University First Hospital, Beijing 100034, China.
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
|September 4, 2024
概括
血管化 (VC) 随着年龄的增长而增加,与健康状况不佳有关. 目前对VC的治疗方法缺乏临床有效性,突出显示了对新型治疗策略的需求.
科学领域:
- 生物医学研究的研究.
- 心血管科学 心血管科学
- 衰老的研究研究.
背景情况:
- 血管化 (VC) 的发生率随着年龄的增长而增加.
- 冠状病毒与心血管事件和死亡率的增加有关.
- 对于VC的现有干预措施尚未证明在逆转或治愈方面具有临床有效性.
研究的目的:
- 对血管化干预措施的新观点进行审查.
- 提供关于VC治疗的临床决策的参考.
主要方法:
- 对最近的VC研究进展进行文献综述.
- 对VC新兴治疗目标和策略的分析.
主要成果:
- 目前针对VC的干预措施在临床实践中表现出有限的成功.
- 目前正在研究针对VC病原性的几种新方法.
结论:
- 迫切需要有效的治疗方法来逆转或治愈血管化.
- 本综述综合了新的见解,以指导未来的临床策略来管理VC.
相关概念视频
Antihypertensive Drugs: Vasodilators
492
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
492
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
464
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
464
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
147
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
147
Vascular Spasm
1.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.3K
Antihypertensive Drugs: Action of Calcium Channel Blockers
473
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
473


